FDA Inspection 1197154 — Origin Biologics LLC

Origin Biologics LLC — FEI 3016678141

The FDA completed an inspection of Origin Biologics LLC on Feb 10, 2023 in Las Vegas, NV. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 7 citations were issued during this inspection. Product area: Biologics.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Feb 10, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Las Vegas, NV (United States)

Citations

IDCFRDescription
1232521 CFR 1271.160(b)(6)Deviations--evaluation, cause, corrective action
1233621 CFR 1271.180(a)Procedures to meet core CTGP
1235621 CFR 1271.195(a)Adequate control, proper conditions
1235921 CFR 1271.195(a)(3)Aseptic processing---cleaning, disinfecting
1237221 CFR 1271.200(c)Calibrated per established schedules
1239921 CFR 1271.230(a)Process validation procedures
1241121 CFR 1271.260(a)Contamination, mix ups, improper release

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.